Atrium Therapeutics, Inc. Common Stock - gráfico, preços e notícias (NASDAQ:RNA) | MetaTrader

Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas

Market Capitalization 1.8398 B
Employee 391
Founded 2025
CEO Troy Wilson
Website www.aviditybiosciences.com
Headquarter Delaware, United States
FIGI BBG01Z0T3959
Industry Technology

Notícias

PGIM Jennison Health Sciences Fund Q4 2025 Key Contributors And Detractors

Morning News Wrap-Up 2/27/26: Today’s Biggest Stock Market Stories! - TipRanks.com

Lucro da Avidity Bio veio abaixo das projeções por $0,30; receita menor do que estimativas

Avidity Bio earnings missed by $0.30, revenue fell short of estimates

Avidity adia assembleia de acionistas e define novas datas para fusão

Avidity postpones stockholder meeting, sets merger dates

BB Biotech apresenta lucro 660% maior em 2025, mas projeta cautela para 2026

Avidity’s myotonic dystrophy drug shows promising results in trial

F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine

Vaccine Makers Curtail Research and Cut Jobs

U.S. Health Officials Defend Rejection of Moderna’s Flu Vaccine

F.D.A. Refuses to Review Moderna Flu Vaccine